Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trial
… the double-blind, placebo-controlled results of the study. All … improvement of MDD symptoms
as assessed by the change from … study was comparable to that seen in other antidepressant …
as assessed by the change from … study was comparable to that seen in other antidepressant …
Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study
C DeBattista, K Doghramji, MA Menza… - Journal of Clinical …, 2003 - psychiatrist.com
… in patients who are starting or switching antidepressant therapy, affording early symptomatic …
Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. …
Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. …
Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study
… The construction was done with normal spalted iron and ferrit… already significant at the end
of the first treatment week (p < .001) … , concentration difficulty, and pain on the scalp in the TMS …
of the first treatment week (p < .001) … , concentration difficulty, and pain on the scalp in the TMS …
… (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomized, double-blind exploratory study
JP Olié, D Gourion, A Montagne, M Rostin… - … disease and treatment, 2010 - Taylor & Francis
… duration of treatment with antidepressants necessary in order … first by the selective serotonin
reuptake inhibitors (SSRIs), … In both cases the values had returned to normal at week 24. …
reuptake inhibitors (SSRIs), … In both cases the values had returned to normal at week 24. …
Novel and emerging treatments for major depression
… or changing synaptic plasticity via the NMDA receptor complex. Esmethadone … double-blind
trial of patients with MDD who had not responded to between one and three antidepressants …
trial of patients with MDD who had not responded to between one and three antidepressants …
… agomelatine (25–50 mg/day) and escitalopram (10–20 mg/day) in outpatients with Major Depressive Disorder. A 12-week randomised double-blind comparative study
T Udristoiu, P Dehelean, P Nuss, V Raba… - Journal of Affective …, 2016 - Elsevier
… ≥2 times the upper normal limit, Alkaline Phosphatase ≥3 … This double-blind, multicentric
randomised study is the first to … symptom with a significant change in the general interest …
randomised study is the first to … symptom with a significant change in the general interest …
Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial
SN Raja, JA Haythornthwaite, M Pappagallo… - Neurology, 2002 - AAN Enterprises
… pain.12,13 Critical analyses of published randomized trials suggest … , double-blind,
placebo-controlled, crossover clinical trial … Correlation between change in pain ratings after …
placebo-controlled, crossover clinical trial … Correlation between change in pain ratings after …
A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression
DJ Hellerstein, JW Stewart, PJ McGrath… - The Journal of clinical …, 2012 - psychiatrist.com
… the efficacy of antidepressants in treating chronic depressive … We report the acute double-blind
phase results in this article. … While our study subjects did not meet criteria for current MDD (…
phase results in this article. … While our study subjects did not meet criteria for current MDD (…
… escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial
E Corruble, C de Bodinat, C Belaïdi… - International Journal of …, 2013 - academic.oup.com
… of patients treated double-blind with the two antidepressants … This was an international,
double-blind, randomized study … mean change from baseline in the FAS) and subsets of patients …
double-blind, randomized study … mean change from baseline in the FAS) and subsets of patients …
Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study
J Raskin, F Wang, YL Pritchett, DJ Goldstein - Pain Medicine, 2006 - academic.oup.com
… Anticonvulsants, antidepressants, antimanics, and regular … in the double-blind, placebo-controlled
studies of duloxetine in … in patients with major depression. The mean age of the …
studies of duloxetine in … in patients with major depression. The mean age of the …